ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,951Medicare Part D Prescriptions Filled, Including Refills

Rank: 382 out of 2429

$463K Total Retail Price of All Prescriptions

Rank: 328 out of 2429

399 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,068 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 410 325 1 3
SIMVASTATIN 270 231 2 1
LISINOPRIL 258 245 3 2
FUROSEMIDE 256 213 4 5
HYDROCODONE-ACETAMINOPHEN 208 92 S3 5 6
POTASSIUM CHLORIDE 191 181 6 14
OMEPRAZOLE 149 131 7 7
WARFARIN SODIUM 125 125 8 11
METFORMIN HCL 125 95 8 8
METOPROLOL TARTRATE 123 111 10 9
SERTRALINE HCL 108 93 11 23
ATORVASTATIN CALCIUM 98 91 12 13
AMLODIPINE BESYLATE 97 94 13 4
GABAPENTIN 93 60 14 18
HYDROCHLOROTHIAZIDE 92 80 15 10
TRAZODONE HCL 92 28 15 50
PRAVASTATIN SODIUM 91 65 17 16
ALENDRONATE SODIUM 90 68 18 20
TAMSULOSIN HCL 83 66 19 29
TRAMADOL HCL 82 68 20 17
LOSARTAN-HYDROCHLOROTHIAZIDE 79 79 21 73
GLIMEPIRIDE 76 69 22 51
LOSARTAN POTASSIUM 70 67 23 22
ADVAIR DISKUS 69 33 24 49
MIRTAZAPINE 69 64 24 63
CARVEDILOL 67 55 26 21
ALLOPURINOL 67 67 26 33
MELOXICAM 65 65 28 40
AZITHROMYCIN 65 58 28 46
MORPHINE SULFATE ER 64 0 S2 30 162
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 52 30 27
CITALOPRAM HBR 63 52 32 19
PAROXETINE HCL 61 49 33 67
ZETIA 59 55 34 70
CYMBALTA 59 44 34 58
FLUTICASONE PROPIONATE 58 34 36 39
TOPIRAMATE 57 29 37 136
ATENOLOL 57 57 37 15
TRIAMTERENE-HCTZ 57 56 37 53
CYCLOBENZAPRINE HCL 57 21 R 37 69
KOMBIGLYZE XR 55 39 41 482
PROAIR HFA 51 33 42 41
LANTUS 51 44 42 45
SINGULAIR 51 19 42 86
PANTOPRAZOLE SODIUM 50 36 45 34
ZOLPIDEM TARTRATE 50 34 45 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.